Therapeutic potential and pharmacological mechanisms of cannabinoids in alleviating chemotherapy-induced organ toxicity and adverse effects.
A comprehensive review examines how cannabinoids chemotherapy organ protection mechanisms could address treatment-limiting toxicities. While theoretical evidence suggests promise through anti-inflammatory and antioxidant pathways, clinical validation…
Cannabis Rescheduling Is Not the Story People Think It Is
The cannabis rescheduling clinical impact is being widely misunderstood. While federal policy shifts from Schedule I to Schedule III signal progress, they do not define how cannabis should be used in medical care. This analysis clarifies what changes,…
Cannabis Brain Health and Aging Brain: Beyond the Headlines
Public discussions regarding cannabis brain health and aging often fail to distinguish between recreational adolescent use and late-life therapeutic guidance. This clinical review breaks down recent data to show why the exposure definition and habit…
How Cannabis Interacts With the Aging Brain and Its Endocannabinoid System
Cannabis aging brain endocannabinoid system research shows that baseline endocannabinoid tone declines with age. This study demonstrates that cannabis produces larger proportional increases in key compounds like anandamide in older adults. These findings…
A Physician’s Interpretation of a 2,500-Study Review
Medical cannabis evidence remains more limited than many patients expect. A large JAMA review of over 2,500 studies highlights where clinical support exists and where it does not. This analysis clarifies what current medical cannabis evidence can…
Zurich’s Cannabis Trial Extension Highlights Swiss Access Models
Switzerland cannabis access models are evolving with Zurich's cannabis trial extension. This trial demonstrates promising safety and efficacy outcomes. The extension highlights important clinical implications for medical cannabis programs.
Cannabinoid-based Interventions for Behavioral Outcomes in Children and Adolescents with Autism Spectrum Disorder
Cannabinoid interventions autism spectrum disorder show promise for improving behavioral outcomes in children and adolescents. This systematic review highlights safety and effectiveness data. Families and clinicians should consider these findings…
Joseph Schradie, 1933-2026: UT Professor and Cannabis Advocate
Joseph Schradie was a pioneer in early academic cannabis advocacy, helping to legitimize medical marijuana research. His work laid the foundation for evidence-based cannabis therapeutics. This advocacy was crucial in shifting academic and clinical…
Faster Cannabinoid Bioavailability: A 2025 Nanoemulsion Study
This cannabinoid bioavailability review examines a 2025 crossover study testing a nanoemulsified THC/CBD powder against standard oil drops in healthy volunteers. The study found faster absorption and higher cannabinoid exposure with the powder…
7 Insights from a New Study on Cannabis Oil for Chronic Pain
Cannabis oil extracts chronic pain relief is gaining attention from new research. A recent study reveals significant pain reduction and improved quality of life. These findings highlight cannabis oil extracts chronic pain management potential.